Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling
Chemo/radio-therapy resistance to the deadly pancreatic cancer is mainly due to the failure to kill pancreatic cancer stem cells (CSCs). Signal transducer and activator of transcription 3 (STAT3) is activated in pancreatic CSCs and, therefore, may be a valid target for overcoming therapeutic resista...
Main Authors: | Wu, Xiaoqing, Tang, Wenhua, Marquez, Rebecca T., Li, Ke, Highfill, Chad A., He, Fengtian, Lian, Jiqin, Lin, Jiayuh, Fuchs, James R., Ji, Min, Li, Ling, Xu, Liang |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905505/ |
Similar Items
-
Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer
by: Szuecs, Marcella, et al.
Published: (2015) -
Stat3 Inhibitor Stattic Exhibits Potent Antitumor Activity and Induces Chemo- and Radio-Sensitivity in Nasopharyngeal Carcinoma
by: Pan, Yunbao, et al.
Published: (2013) -
Influence of Interferon-Alpha Combined with Chemo (Radio) Therapy on Immunological Parameters in Pancreatic Adenocarcinoma
by: Karakhanova, Svetlana, et al.
Published: (2014) -
Rational combination of MEK inhibitor and the STAT3 pathway modulator for the therapy in K-Ras mutated pancreatic and colon cancer cells
by: Zhao, Chengguang, et al.
Published: (2015) -
Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer
by: Li, Ling, et al.
Published: (2016)